Home » Market News » DirectorsTalk Highlights » Global Autoimmune Diseases Drugs Market Size to Grow at a CAGR of 5.57% during 2016-2020
Immupharma Plc

Global Autoimmune Diseases Drugs Market Size to Grow at a CAGR of 5.57% during 2016-2020

A market study, titled “Global Autoimmune Drugs Market 2016-2020,” has been featured on MarketResearchReports.biz’s online repository of market intelligence. This research report provides the answers to some of the pertinent questions in the realm of autoimmune disorder studies and their associated industries. In this report, various aspects of autoimmune disorders are examined that will mark trends and growth prospects in the global autoimmune drugs market in the future. Market size estimates and information about the changing competitive hierarchy is provided for the 2016-2020 period across the Americas, EMEA, and APAC regions.


The report presents data about the top vendors in the global autoimmune drugs market, which are AbbVie Inc., Amgen Inc., F.Hoffmann-La Roche, Pfizer Inc., Biogen, and Johnson & Johnson Private Limited. Other prominent vendors in this market Eisai, AstraZeneca, Antares Pharma, Gilead Sciences, Daiichi Sankyo, Sandoz, AB Science, Morphotek, Lexicon Pharmaceuticals, Santarus, Vitae Pharmaceuticals, Immunomedics, Principia Biopharma, Celltrion, Boehringer Ingelheim, Astellas Pharma, Hospira, Coherus BioSciences, Alder BioPharmaceuticals, Can-Fite BioPharma, Novartis, KaloBios Pharmaceuticals, Novo Nordisk, Idera Pharmaceuticals, MedImmune, ChemoCentryx, Invion, Celgene, Sanofi, Merck, Ablynx, Opexa Therapeutics, Acorda Therapeutics, ImmuPharma PLC (LON:IMM), Regeneron Pharmaceuticals, Baxter, GSK, Incyte, Takeda Pharmaceuticals, and Eli Lilly.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.